Acquired disorders affecting megakaryocytes and platelets

Blood and Bone Marrow Pathology

Volumn , Issue , 2011, Pages 523-545

  Provan, D ^a   Newland, A C ^b   MacCallum, P K ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882470658     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3147-2.00033-X     Document Type: Chapter

References (144)

1. Long MW, Gragowski LL, Heffner CH, Boxer LA Phorbol diesters stimulate the development of an early murine progenitor cell. The burst-forming unit-megakaryocyte. J Clin Invest 1985, 76:431-438.
2. Jackson CW Megakaryocyte endomitosis: a review. Int J Cell Cloning 1990, 8:224-226.
3. Harker LA, Finch CA Thrombokinetics in man. J Clin Invest 1969, 48:963-974.
4. Hynes RO Integrins: a family of cell surface receptors. Cell 1987, 48:549-554.
5. Kasirer-Friede A, Kahn ML, Shattil SJ Platelet integrins and immunoreceptors. Immunol Rev 2007, 218:247-264.
6. Kieffer N, Phillips DR Platelet membrane glycoproteins: functions in cellular interactions. Annu Rev Cell Biol 1990, 6:329-357.
7. Kunicki TJ, Newman PJ The molecular immunology of human platelet proteins. Blood 1992, 80:1386-1404.
8. Nachman RL, Rafii S Platelets, petechiae, and preservation of the vascular wall. N Engl J Med 2008, 359:1261-1270.
9. Payne BA, Pierre RV Pseudothrombocytopenia: a laboratory artifact with potentially serious consequences. Mayo Clin Proc 1984, 59:123-125.
10. Savage RA Pseudoleukocytosis due to EDTA-induced platelet clumping. Am J Clin Pathol 1984, 81:317-322.
11. Aster RH Pooling of platelets in the spleen: role in the pathogenesis of 'hypersplenic' thrombocytopenia. J Clin Invest 1966, 45:645-657.
12. Gewirtz AM, Hoffman R Transitory hypomegakaryocytic thrombocytopenia: aetiological association with ethanol abuse and implications regarding regulation of human megakaryocytopoiesis. Br J Haematol 1986, 62:333-344.
13. Manoharan A, Williams NT, Sparrow R Acquired amegakaryocytic thrombocytopenia: report of a case and review of literature. Q J Med 1989, 70:243-252.
14. Boggs DR Amegakaryocytic thrombocytopenia. Am J Hematol 1985, 20:413-416.
15. Levi M, ten Cate H, van der Poll T, van Deventer SJ Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993, 270:975-979.
16. Zheng XL, Sadler JE Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol 2008, 3:249-277.
17. Moschowitz E Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proceedings of the New York Pathological Society 1924, 24:21-24.
18. Allford SL, Hunt BJ, Rose P, Machin SJ Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 2003, 120:556-573.
19. George JN Clinical practice. Thrombotic thrombocytopenic purpura. NEJM 2006, 354:1927-1935.
20. Schleinitz N, Ebbo M, Mazodier K, et al. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor. Am J Hematol 2007, 82:417-418.
21. Scott SM, Szczepiorkowski ZM Rituximab for TTP. Am J Hematol 2005, 80:87-88.
22. Gasser C, Gautier E, Steck A, et al. [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia.]. Schweiz Med Wochenschr 1955, 85:905-909.
23. Ashkenazi S Role of bacterial cytotoxins in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Annu Rev Med 1993, 44:11-18.
24. Neill MA, Agosti J, Rosen H Hemorrhagic colitis with E scherichia coli 0157:H7 preceding adult hemolytic uremic syndrome. Arch Intern Med 1985, 145:2215-2217.
25. Martin DL, MacDonald KL, White KE, et al. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med 1990, 323:1161-1167.
26. Milford DV, Taylor CM, Guttridge B, et al. Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing E scherichia coli. Part 1: Clinical and epidemiological aspects. Arch Dis Child 1990, 65:716-721.
27. Delvaeye M, Noris M, De Vriese A, et al. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 2009, 361:345-357.
28. Rowe PC, Orrbine E, Wells GA, McLaine PN Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre. J Pediatr 1991, 119:218-224.
29. Brenner BM Vascular injury to the kidney. Principles of Internal Medicine 1998, McGraw-Hill, New York. A.S. Fauci, E. Braunwald, K.J. Isselbacher .
30. Ishibashi M, Ito N, Fujita M, et al. Endothelin-1 as an aggravating factor of disseminated intravascular coagulation associated with malignant neoplasms. Cancer 1994, 73:191-195.
31. Jones SL HELLP! A cry for laboratory assistance: a comprehensive review of the HELLP syndrome highlighting the role of the laboratory. Hematopathol Mol Hematol 1998, 11:147-171.
32. Portis R, Jacobs MA, Skerman JH, Skerman EB HELLP syndrome pathophysiology and anesthetic considerations. AANA J 1997, 65:37-47.
33. Stone JH HELLP syndrome: hemolysis, elevated liver enzymes, and low platelets. JAMA 1998, 280:559-562.
34. Sheikh RA, Yasmeen S, Pauly MP, Riegler JL Spontaneous intrahepatic hemorrhage and hepatic rupture in the HELLP syndrome: four cases and a review. Journal of Clinical Gastroenterology 1999, 28:323-328.
35. Hamada S, Takishita Y, Tamura T, et al. Plasma exchange in a patient with postpartum HELLP syndrome. J Obstet Gynaecol Res 1996, 22:371-374.
36. Counts RB, Haisch C, Simon TL, et al. Hemostasis in massively transfused trauma patients. Ann Surg 1979, 190:91-99.
37. Leslie SD, Toy PT Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am J Clin Pathol 1991, 96:770-773.
38. Lindenbaum J, Hargrove RL Thrombocytopenia in alcoholics. Ann Intern Med 1968, 68:526-532.
39. Post RM, Desforges JF Thrombocytopenia and alcoholism. Ann Intern Med 1968, 68:1230-1236.
40. Kelly DA, Summerfield JA Hemostasis in liver disease. Semin Liver Dis 1987, 7:182-191.
41. Ninomiya N, Maeda T, Matsuda I Thrombocytopenic purpura occurring during the early phase of a mumps infection. Helv Paediatr Acta 1977, 32:87-89.
42. Espinoza C, Kuhn C Viral infection of megakaryocytes in varicella with purpura. Am J Clin Pathol 1974, 61:203-208.
43. Angle RM, Alt HL. Thrombocytopenic purpura complicating infectious mononucleosis. Blood 1050;5:499.
44. Bayer WL, Sherman FE, Michaels RH, et al. Purpura in congenital and acquired rubella. N Engl J Med 1965, 273:1362-1366.
45. Oski FA, Naiman JL Effect of live measles vaccine on the platelet count. N Engl J Med 1966, 275:352-356.
46. Ballem PJ, Belzberg A, Devine DV, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 1992, 327:1779-1784.
47. Yang R, Zhong CH Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update. International Journal of Hematology 2000, 71:1824.
48. Walsh CM, Nardi MA, Karpatkin S On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med 1984, 311:635-639.
49. Abrams DI, Chinn EK, Lewis BJ, et al. Hematologic manifestations in homosexual men with Kaposi's sarcoma. Am J Clin Pathol 1984, 81:13-18.
50. Frontiera M, Myers AM Peripheral blood and bone marrow abnormalities in the acquired immunodeficiency syndrome. West J Med 1987, 147:157-160.
51. Treacy M, Lai L, Costello C, Clark A Peripheral blood and bone marrow abnormalities in patients with HIV related disease. Br J Haematol 1987, 65:289-294.
52. Rossi G, Gorla R, Stellini R, et al. Prevalence, clinical, and laboratory features of thrombocytopenia among HIV-infected individuals. AIDS Res Hum Retroviruses 1990, 6:261-269.
53. Stabler SP, Allen RH, Savage DG, Lindenbaum J Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990, 76:871-881.
54. van Loghem JJ, Dorfmeyer H, van de Hart M, Schreuder F Serological and genetical studies on the platelet antigen . Vox Sanguinis 1959, 4:161-169.
55. Mueller-Eckhardt C, Becker T, Weisheit M, et al. Neonatal alloimmune thrombocytopenia due to fetomaternal Zwb incompatibility. Vox Sang 1986, 50:94-96.
56. Bizzaro N, Dianese G Neonatal alloimmune amegakaryocytosis. Case report. Vox Sang 1988, 54:112-114.
57. von dem Borne AE, von Riesz E, Verheugt FW, et al. Baka, a new platelet-specific antigen involved in neonatal allo-immune thrombocytopenia. Vox Sang 1980, 39:113-120.
58. McGrath K, Minchinton R, Cunningham I, Ayberk H Platelet anti-Bakb antibody associated with neonatal alloimmune thrombocytopenia. Vox Sang 1989, 57:182-184.
59. Friedman JM, Aster RH Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a 'new' maternal antiplatelet antibody. Blood 1985, 65:1412-1415.
60. Shibata Y, Matsuda I, Miyaji T, Ichikawa Y Yuka, a new platelet antigen involved in two cases of neonatal alloimmune thrombocytopenia. Vox Sang 1986, 50:177-180.
61. Kaplan C, Morel-Kopp MC, Kroll H, et al. HPA-5b ) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. Br J Haematol 1991, 78:425-429.
62. Kiefel V, Shechter Y, Atias D, et al. Neonatal alloimmune thrombocytopenia due to anti-Brb . Report of three cases in two families. Vox Sang 1991, 60:244-245.
63. Mueller-Eckhardt C, Kayser W, Forster C, et al. Improved assay for detection of platelet-specific PlA1 antibodies in neonatal alloimmune thrombocytopenia. Vox Sang 1982, 43:76-81.
64. Katz J, Hodder FS, Aster RS, et al. Neonatal isoimmune thrombocytopenia. The natural course and management and the detection of maternal antibody. Clin Pediatr 1984, 23:159-162.
65. Adner MM, Fisch GR, Starobin SG, Aster RH Use of 'compatible' platelet transfusions in treatment of congenital isoimmune thrombocytopenic purpura. N Engl J Med 1969, 280:244-247.
66. Suarez CR, Anderson C High-dose intravenous gammaglobulin in neonatal immune thrombocytopenia. Am J Hematol 1987, 26:247-253.
67. Pearson HA, Shulman NR, Marder VJ, Cone TE Isoimmune neonatal thrombocytopenic purpura: clinical and therapeutic considerations. Blood 1964, 23:154.
68. McFarland JG, Aster RH, Bussel JB, et al. Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes. Blood 1991, 78:2276-2282.
69. Mueller-Eckhardt C Post-transfusion purpura. Br J Haematol 1986, 64:419-424.
70. Taaning E, Morling N, Ovesen H, Svejgaard A Post transfusion purpura and anti-Zwb . Tissue Antigens 1985, 26:143-146.
71. Keimowitz RM, Collins J, Davis K, Aster RH Post-transfusion purpura associated with alloimmunization against the platelet-specific antigen, Baka. Am J Hematol 1986, 21:79-88.
72. Kickler TS, Ness PM, Herman JH, Bell WR Studies on the pathophysiology of posttransfusion purpura. Blood 1986, 68:347-350.
73. Christie DJ, Pulkrabek S, Putnam JL, et al. Posttransfusion purpura due to an alloantibody reactive with glycoprotein Ia/IIa . Blood 1991, 77:2785-2789.
74. Seidenfeld AM, Owen J, Glynn MF Post-transfusion purpura cured by steroid therapy in a man. Can Med Assoc J 1978, 118:1285-1286.
75. Simon T, Collins J, Kunicki T Post-transfusion purpura with antiplatelet antibody specific for the platelet antigen Pena. Blood 1986, 68:117a.
76. Waters AH Post-transfusion purpura. Blood Rev 1989, 3:83-87.
77. Nugent D, McMillan R, Nichol JL, Slichter SJ Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol 2009, 146:585-596.
78. McMillan R Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 1997, 126:307-314.
79. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996, 88:3-40.
80. Warner MN, Moore JC, Warkentin TE, et al. A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol 1999, 104:442-447.
81. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009, 113:2386-2393.
82. Bolton-Maggs PH, Moon I Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 1997, 350:620-623.
83. Buchanan GR The nontreatment of childhood idiopathic thrombocytopenic purpura. Eur J Pediatr 1987, 146:107-112.
84. Imbach P Immune thrombocytopenia in children: the immune character of destructive thrombocytopenia and the treatment of bleeding. Semin Thromb Hemost 1995, 21:305-312.
85. Imbach PA, Kuhne T, Hollander G Immunologic aspects in the pathogenesis and treatment of immune thrombocytopenic purpura in children. Curr Opin Pediatr 1997, 9:35-40. [published erratum appears in Curr Opin Pediatr 1997 Jun;9:298].
86. Baatout S Thrombopoietin. A review. Haemostasis 1997, 27:1-8.
87. Kaushansky K The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005, 115:3339-3347.
88. Kaushansky K Thrombopoietin and the hematopoietic stem cell. Ann N Y Acad Sci 2005, 1044:139-141.
89. Lilleyman JS Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Arch Dis Child 1994, 71:251-253.
90. Kienast J, Schmitz G Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 1990, 75:116-121.
91. Woods VLJ, Kurata Y, Montgomery RR, et al. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura. Blood 1984, 64:156-160.
92. Woods VLJ, Oh EH, Mason D, McMillan R Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood 1984, 63:368-375.
93. Mackay IR Science, medicine, and the future: tolerance and autoimmunity. BMJ 2000, 321:93-96.
94. Hou M, Stockelberg D, Kutti J, Wadenvik H Glycoprotein IIb/IIIa autoantigenic repertoire in chronic idiopathic thrombocytopenic purpura. Br J Haematol 1995, 91:971-975.
95. McMillan R, Tani P, Millard F, et al. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987, 70:1040-1045.
96. Varon D, Karpatkin S A monoclonal anti-platelet antibody with decreased reactivity for autoimmune thrombocytopenic platelets. Proc Natl Acad Sci USA 1983, 80:6992-6995.
97. Fujisawa K, Tani P, O'Toole TE, et al. Different specificities of platelet-associated and plasma autoantibodies to platelet GPIIb-IIIa in patients with chronic immune thrombocytopenic purpura. Blood 1992, 79:1441-1446.
98. Kekomaki R, Dawson B, McFarland J, Kunicki TJ Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa. J Clin Invest 1991, 88:847-854.
99. Nugent DJ, Kunicki TJ, Berglund C, Bernstein ID A human monoclonal autoantibody recognizes a neoantigen on glycoprotein IIIa expressed on stored and activated platelets. Blood 1987, 70:16-22.
100. Young NS, Barrett AJ The treatment of severe acquired aplastic anemia. Blood 1995, 85:3367-3377.
101. Provan A Management of adult idiopathic thrombocytopenic purpura. Prescribers' Journal 1992, 32:193-200.
102. Provan D, Newland A Idiopathic thrombocytopenic purpura in adults. J Pediatr Hematol Oncol 2003, 25):S34-S38.
103. Cahill MR, Macey MG, Cavenagh JD, Newland AC Protein A immunoadsorption in chronic refractory ITP reverses increased platelet activation but fails to achieve sustained clinical benefit. Br J Haematol 1998, 100:358-364.
104. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010, 115:168-186.
105. Newland A Thrombopoietin receptor agonists in the treatment of thrombocytopenia. Curr Opin Hematol 2009, 16:357-364.
106. Bussel JB, Provan D, Shamsi T, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet 2009, 373:641-648.
107. Molineux G, Newland A Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside. Br J Haematol. 2010, 150:9-20.
108. Garratty G Drug-induced immune cytopenia. Transfus Med Rev 1993, 7:213-214.
109. Connellan JM, Deacon S, Thurlow PJ Changes in platelet function and reactivity induced by quinine in relation to quinine induced immune thrombocytopenia. Thromb Res 1991, 61:501-514.
110. Kunicki TJ, Christie DJ, Aster RH The human platelet receptor for quinine/quinidine-dependent antibodies. Blood Cells 1983, 9:293-301.
111. Salom IL Purpura due to inhaled quinidine. JAMA 1991, 266:1220.
112. Curtis BR, McFarland JG, Wu GG, et al. Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood 1994, 84:176-183.
113. Coblyn JS, Weinblatt M, Holdsworth D, Glass D Gold-induced thrombocytopenia. A clinical and immunogenetic study of twenty-three patients. Ann Intern Med 1981, 95:178-181.
114. ASTER AND BORIGIE, NEJM, 2007.
115. Warkentin TE, Chong BH, Greinacher A Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998, 79:1-7.
116. Greinacher A Heparin-induced thrombocytopenia. J Thromb Haemost 2009, 7:9-12.
117. Shantsila E, Lip GY, Chong BH Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management. Chest 2009, 135:1651-1664.
118. Manohitharajah SM, Jenkins WJ, Roberts PD, Clarke RC Methyldopa and associated thrombocytopenia. Br Med J 1971, 1:494.
119. Epstein M, Vickars L, Stein H Diclofenac induced immune thrombocytopenia. J Rheumatol 1990, 17:1403-1404.
120. Burnette PK, Ameer B, Hoang V, Phifer W Rifampin-associated thrombocytopenia secondary to poor compliance. DICP 1989, 23:382-384.
121. Casasin T, Allende A, Macia M, Guell R Two episodes of carbamazepine-induced severe thrombocytopenia in the same child. Ann Pharmacother 1992, 26:715-716.
122. George JN, El-Harake M Thrombocytopenia due to enhanced platelet destruction by non-immunologic mechanisms. Williams Hematology 1995, McGraw-Hill, New York. E. Beutler, M.A. Lichtman, B.S. Coller, T.J. Kipps .
123. Rabiner SF Uremic bleeding. Prog Hemost Thromb 1972, 1:233-250.
124. Remuzzi G Bleeding disorders in uremia: pathophysiology and treatment. Adv Nephrol Necker Hosp 1989, 18:171-186.
125. Castaldi PA, Rozenberg MC, Stewart JH The bleeding disorder of uraemia. A qualitative platelet defect. Lancet 1966, 2:66-69.
126. Livio M, Benigni A, Remuzzi G Coagulation abnormalities in uremia. Semin Nephrol 1985, 5:82-90.
127. Remuzzi G, Livio M, Marchiaro G, et al. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 1978, 22:347-353.
128. Castillo R, Lozano T, Escolar G, et al. Defective platelet adhesion on vessel subendothelium in uremic patients. Blood 1986, 68:337-342.
129. Zwaginga JJ, Ijsseldijk MJ, Beeser-Visser N, et al. High von Willebrand factor concentration compensates a relative adhesion defect in uremic blood. Blood 1990, 75:1498-1508.
130. Zwaginga JJ, Ijsseldijk MJ, de Groot PG, et al. Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma. Arterioscler Thromb 1991, 11:733-744.
131. Weiss HJ, Turitto VT, Baumgartner HR Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate - dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med 1978, 92:750-764.
132. Murphy S Polycythemia vera. Dis Mon 1992, 38:153-212.
133. Schafer AI Essential thrombocythemia. Prog Hemost Thromb 1991, 10:69-96.
134. Ginsburg AD Platelet function in patients with high platelet counts. Ann Intern Med 1975, 82:506-511.
135. Schafer AI Deficiency of platelet lipoxygenase activity in myeloproliferative disorders. N Engl J Med 1982, 306:381-386.
136. n a patient with chronic myeloid leukaemia. Br J Haematol 1982, 51:469-477.
137. Kaplan ME, Mack K, Goldberg JD, et al. Long-term management of polycythemia vera with hydroxyurea: a progress report. Semin Hematol 1986, 23:167-171.
138. Kessler CM, Klein HG, Havlik RJ Uncontrolled thrombocytosis in chronic myeloproliferative disorders. Br J Haematol 1982, 50:157-167.
139. Murphy S, Iland H, Rosenthal D, Laszlo J Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 1986, 23:177-182.
140. Cowan DH, Haut MJ Platelet function in acute leukemia. J Lab Clin Med 1972, 79:893-905.
141. Meschengieser S, Blanco A, Maugeri N, et al. Platelet function and intraplatelet von Willebrand factor antigen and fibrinogen in myelodysplastic syndromes. Thromb Res 1987, 46:601-606.
142. Mackie IJ The biology of haemostasis and thrombosis. Concise Oxford Textbook of Medicine 2000, Oxford University Press, Oxford. J.G.G. Ledingham, D.A. Warrell .
143. Roth GJ Developing relationships: arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoproteins. Blood 1991, 77:5-19.
144. Amiral J, Meyer D Heparin-induced thrombocytopenia: diagnostic tests and biological mechanisms. Baillière's Clinical Haematology 1998, 11:447-460.